Saccharomyces cerevisiae fungemia in a head and neck cancer patient: a case report and review of the literature.

HENRY, Stéphanie;D'Hondt, Lionel;André, Marc;Holemans, X;Canon, J L
(2004) Acta Clinica Belgica — Vol. 59, n° 4, p. 220-222 (2021)

Files

HenrySActaClinBelg2004.pdf
  • Open Access
  • Adobe PDF
  • 198.97 KB
Download

Details

Authors
Abstract
We report the case of a 65-year old male who developed Saccharomyces cerevisiae fungemia after completing a course of concomitant chemotherapy and radiation therapy for head and neck carcinoma. He had grade IV oral mucositis, and received Saccharomyces boulardii (Perenterol) orally as treatment for aseptic diarrhoea just before the onset of fungemia. We discuss the epidemiology and pathology of Saccharomyces cerevisiae in the cancer patient population.
Affiliations

Citations

  • APA
  • Chicago
  • FWB

HENRY, S., D’Hondt, L., André, M., Holemans, X., & Canon, J. L. (2004). Saccharomyces cerevisiae fungemia in a head and neck cancer patient: a case report and review of the literature. Acta Clinica Belgica, 59(4), 220-222. https://doi.org/10.1179/acb.2004.032 (Original work published 2021)